The multiple sclerosis (MS) neurotherapeutic landscape is rapidly evolving. New disease-
modifying therapies (DMTs) with improved efficacy and safety, in addition to an expanding …

Autoimmune diseases are a diverse and complex set of chronic disorders with a substantial
impact on patient quality of life and a significant global healthcare burden. Current …

Multiple sclerosis (MS) is an autoimmune disorder causing demyelination and
neurodegeneration in the central nervous system. MS is characterized by disturbed motor …

Introduction Multiple sclerosis (MS) is the most common demyelinating disease of the central
nervous system (CNS). Although there are several disease-modifying therapies that can …

Juvenile idiopathic arthritis (JIA) is the most common rheumatic disease in childhood, while
multiple sclerosis (MS) is a demyelinating disease of the central nervous system …

It has been rediscovered in the last fifteen years that B-cells play an active role in
autoimmune etiology rather than just being spectators. The clinical success of B-cell …

Introduction: Rosa webbiana (RW) Wall Ex. Royle is used in traditional medicine in Pakistan
for the treatment of several diseases including jaundice. To date, only neuroprotective …

Multiple sclerosis is an autoimmune disease that affects the central nervous system. In
Brazil, there are currently several therapeutic options for the treatment of this condition, with …

The aim of the retrospective study was to compare the immunophenotyping of T-
lymphocytes, B-lymphocytes, and natural killer cells before the administration of the first and …

Background Multiple sclerosis (MS) is a debilitating neurological disease characterized by
inflammation, demyelination, and neurodegeneration in the central nervous system. Despite …